Long-Term Treatment Sequelae After External Beam Irradiation With or Without Hormonal Manipulation for Adenocarcinoma of the Prostate: Analysis of Radiation Therapy Oncology Group Studies 85-31, 86-10, and 92-02

This publication has 9 references indexed in Scilit:

• Ten-Year Follow-Up of Radiation Therapy Oncology Group Protocol 92-02: A Phase III Trial of the Duration of Elective Androgen Deprivation in Locally Advanced Prostate Cancer
  Journal of Clinical Oncology, 2008
• Androgen suppression adjuvant to definitive radiotherapy in prostate carcinoma—long-term results of phase III RTOG 85–31
  International Journal of Radiation Oncology*Biology*Physics, 2005
• Impact of neoadjuvant androgen ablation and other factors on late toxicity after external beam prostate radiotherapy
  International Journal of Radiation Oncology*Biology*Physics, 2004
• Phase III Trial of Long-Term Adjuvant Androgen Deprivation After Neoadjuvant Hormonal Cytoreduction and Radiotherapy in Locally Advanced Carcinoma of the Prostate: The Radiation Therapy Oncology Group Protocol 92–02
  Journal of Clinical Oncology, 2003
• Adjuvant androgen deprivation impacts late rectal toxicity after conformal radiotherapy of prostate carcinoma
  British Journal of Cancer, 2002
• Phase III radiation therapy oncology group (RTOG) trial 86-10 of androgen deprivation adjuvant to definitive radiotherapy in locally advanced carcinoma of the prostate
  International Journal of Radiation Oncology*Biology*Physics, 2001
• Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European organization for research and treatment of cancer (EORTC)
  International Journal of Radiation Oncology*Biology*Physics, 1995
• Long-term treatment sequelae following external beam irradiation for adenocarcinoma of the prostate: analysis of RTOG studies 7506 and 7706
  International Journal of Radiation Oncology*Biology*Physics, 1991
• Regression Models and Life-Tables
  Journal of the Royal Statistical Society Series B: Statistical Methodology, 1972